Page last updated: 2024-10-26

3,3'-diindolylmethane and Colorectal Neoplasms

3,3'-diindolylmethane has been researched along with Colorectal Neoplasms in 6 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Although 3,3'-diindolylmethane (DIM) has been suggested to reduce the risk of colorectal cancer, the underlying biological mechanism is not clearly understood."7.81FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells. ( Jin, H; Kim, SM; Li, XJ; Park, MH, 2015)
"Although 3,3'-diindolylmethane (DIM) has been suggested to reduce the risk of colorectal cancer, the underlying biological mechanism is not clearly understood."3.81FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells. ( Jin, H; Kim, SM; Li, XJ; Park, MH, 2015)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gao, X1
Liu, J1
Cho, KB1
Kedika, S1
Guo, B1
Zhang, X2
Sukamporn, P1
Zhang, S1
Min, KW2
Baek, SJ2
Clark, R1
Lee, J1
Lee, SH2
Jin, H1
Li, XJ1
Park, MH1
Kim, SM1
Bahrami, A1
Amerizadeh, F1
ShahidSales, S1
Khazaei, M1
Ghayour-Mobarhan, M1
Sadeghnia, HR1
Maftouh, M1
Hassanian, SM1
Avan, A1

Reviews

1 review available for 3,3'-diindolylmethane and Colorectal Neoplasms

ArticleYear
Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:8

    Topics: Animals; Antineoplastic Agents; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Prolifer

2017

Other Studies

5 other studies available for 3,3'-diindolylmethane and Colorectal Neoplasms

ArticleYear
Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells.
    International journal of molecular sciences, 2020, Jun-30, Volume: 21, Issue:13

    Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neop

2020
3,3'-diindolylmethane downregulates cyclin D1 through triggering endoplasmic reticulum stress in colorectal cancer cells.
    Oncology reports, 2017, Volume: 38, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclin D1; Down-Regulation

2017
Synergistic anticancer activity of capsaicin and 3,3'-diindolylmethane in human colorectal cancer.
    Journal of agricultural and food chemistry, 2015, May-06, Volume: 63, Issue:17

    Topics: Antineoplastic Agents; Apoptosis; Capsaicin; Cell Line, Tumor; Cell Proliferation; Colorectal Neopla

2015
FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells.
    Oncology reports, 2015, Volume: 33, Issue:6

    Topics: Cadherins; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Forkhead Box Protein M1; Forkhea

2015
3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.
    The Journal of nutritional biochemistry, 2013, Volume: 24, Issue:4

    Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Cell Line, Tumor; Colorectal N

2013